Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06513663 · ClinicalTrials.gov registry record · NA

Exercise as Maintenance Therapy in Advanced Lung Cancer

A NA study of Non-Small Cell Lung Cancer and Lung Cancer, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
3
Study locations

NCT06513663 is a NA study of Non-Small Cell Lung Cancer and Lung Cancer that is actively recruiting participants, run by Indiana University. The registered enrollment target is 100 participants, below the 659-participant average among 449 other Non-Small Cell Lung Cancer trials with a reported enrollment target (85% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06513663, a NA study of Non-Small Cell Lung Cancer and Lung Cancer, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to examine how a multimodality (having or using a variety of methods to do something) exercise intervention may improve survival, function, and quality of life in participants with advanced lung cancer.

Interventions

  • BEHAVIORAL Exercise Intervention

Study Locations (3)

Indiana

  • Indiana University Health Methodist Hospital - Indianapolis
  • Indiana University Melvin & Bren Simon Comprehensive Cancer Center - Indianapolis
  • Sidney and Lois Eskenazi Hospital - Indianapolis

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-10-15
Est. Completion 2029-12
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT06513663

The ClinicalTrials.gov registry entry for NCT06513663 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 659-participant average among 449 other Non-Small Cell Lung Cancer trials with a reported enrollment target (85% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Non-Small Cell Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Exercise Intervention is the first listed.

NCT06513663 reports 3 study locations spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT06513663 about?

NCT06513663 is a clinical study titled "Exercise as Maintenance Therapy in Advanced Lung Cancer". The purpose of this study is to examine how a multimodality (having or using a variety of methods to do something) exercise intervention may improve survival, function, and quality of life in participants with advanced lung cancer.

What is the current status of trial NCT06513663?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-10-15. Estimated completion is 2029-12.

What conditions does trial NCT06513663 study?

This clinical trial studies the following conditions: Non-Small Cell Lung Cancer, Lung Cancer, Metastatic Lung Cancer.

What interventions are being tested in trial NCT06513663?

The interventions under investigation include: Exercise Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06513663?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06513663 being conducted?

This trial has 3 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Non-Small Cell Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.